Work

Risk of Heart Failure in Patients With Nonalcoholic Fatty Liver Disease

Year: 2022

Type: review

Source: Journal of the American College of Cardiology

DOI: 10.1016/j.jacc.2021.11.007

Authors: Alessandro Mantovani, Christopher D. Byrne, Giovanni Benfari, Stefano Bonapace, Tracey G. Simon, Giovanni Targher

Institutions: University of Verona, Azienda Ospedaliera Universitaria Integrata Verona, Southampton General Hospital, University Hospital Southampton NHS Foundation Trust, National Institute for Health and Care Research, Ospedale Sacro Cuore Don Calabria, Harvard University, Massachusetts General Hospital

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institute for Health and Care Research, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G4492105040, Aspirin and Novel Lipid Mediators in Nonalcoholic Fatty Liver Disease

OpenAlex ID: W4206332157

FWCI: 3.933

Cites: 82

Cited by: 115

Related to: 10